Journal ArticleOPEN ACCESS

Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy

  • Yun J
  • Kim K
  • Kim S
  • et al.
Cancer Research and Treatment (2010) 42(2) 101
DOI: 10.4143/crt.2010.42.2.101
N/ACitations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study was to determine whether the ERCC1 expression is effective to predict the clinical outcomes of patients with advanced gastric cancer (AGC) and who were treated with cisplatin-based first-line chemotherapy.

Cite

CITATION STYLE

APA

Yun, J., Kim, K.-M., Kim, S. T., Kim, J.-H., Kim, J. A., Kong, J. H., … Kang, W. K. (2010). Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy. Cancer Research and Treatment, 42(2), 101. https://doi.org/10.4143/crt.2010.42.2.101

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free